Oral pharmaceutical composition for preventing or treating dry eye syndrome comprising rebamipide or a prodrug thereof
AssigneesSamjin Pharmaceutical Co., Ltd., Astech, Inc.
InventorsEui Hwan CHO, Sung Ju CHOI, Sung Woo LEE, Hee Jong SHIN, Jong Bae YOON, Ki Seok PARK, Ho Tae NAM
Life of this patent
Estimating the term…
Abstract
Disclosed is an oral pharmaceutical composition for preventing or treating dry eye syndrome, which comprises rebamipide or a prodrug thereof, or a pharmaceutically acceptable salt thereof, as an active ingredient. The compounds can treat dry eye syndrome via oral route, and can be thus employed safely and conveniently compared to conventional eye drops.
Claims20
A method of preventing or treating dry eye syndrome in a subject in need thereof, comprising:
- providing an oral pharmaceutical composition comprising rebamipide or a prodrug thereof, or a pharmaceutically acceptable salt thereof, as an active ingredient;
- and
- administering the pharmaceutical composition orally to the subject.
(canceled)
11-12. (canceled)
An oral pharmaceutical composition, comprising rebamipide or a prodrug thereof, or a pharmaceutically acceptable salt thereof, as an active ingredient.
Dependencies are inferred from the claim text.